Breaking News, Collaborations & Alliances

BostonGene, AstraZeneca Partner to Advance Oncology Drug Development

AstraZeneca will apply BostonGene’s omnimodal analytics to accelerate development timelines and reduce risk across its oncology portfolio.

Author Image

By: Charlie Sternberg

Associate Editor

BostonGene, the developer of an AI foundation model for tumor and immune biology, has entered a strategic collaboration with AstraZeneca, a global biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, to advance oncology drug development using BostonGene’s multimodal AI platform. The collaboration leverages BostonGene’s foundation model for tumor and immune biology to deliver pred...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters